-Only MCED test to use a urine sample collected at home instead of blood draw. -Only MCED to detect stage I/II cancers with 97% sensitivity and 97% specificity. -Offered as a laboratory-developed test ...
The use of analytical tools in test preparations will offer immense growth opportunities. To make most of the opportunities, market vendors should focus more on the growth prospects in the ...
A proposal for community standards in clinical trials descriptions and reporting. The NEXT-2 (Next Generation Personalized Tx with Plasma DNA Genomics Trial-2 in Refractory Solid Tumors: cfDNA-Based ...
LONDON--(BUSINESS WIRE)--The test preparation market in the US is expected to post a CAGR of almost 6% during the period 2019-2023, according to the latest market research report by Technavio. Request ...
SAN DIEGO, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing ...
A fresh web-based test management platform is rolling out to streamline mobile device testing workflows, centralize data, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results